Newman Dignan & Sheerar Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Buy
16,944
+15
+0.1% +$392 0.08% 140
2026
Q1
$475K Sell
16,929
-569
-3% -$15.1K 0.1% 126
2025
Q4
$436K Buy
17,498
+1,870
+12% +$47.2K 0.09% 127
2025
Q3
$398K Sell
15,628
-17
-0.1% -$420 0.09% 131
2025
Q2
$379K Sell
15,645
-1,568
-9% -$36.6K 0.09% 134
2025
Q1
$436K Sell
17,213
-222
-1% -$5.81K 0.12% 110
2024
Q4
$463K Sell
17,435
-706
-4% -$19.1K 0.12% 112
2024
Q3
$524K Sell
18,141
-1,340
-7% -$39.1K 0.13% 112
2024
Q2
$545K Sell
19,481
-730
-4% -$20.1K 0.14% 108
2024
Q1
$561K Sell
20,211
-3,337
-14% -$92.6K 0.15% 110
2023
Q4
$678K Sell
23,548
-7,778
-25% -$235K 0.2% 100
2023
Q3
$1.04M Sell
31,326
-1,416
-4% -$50.1K 0.34% 74
2023
Q2
$1.2M Buy
32,742
+9
+0% +$350 0.37% 71
2023
Q1
$1.34M Sell
32,733
-91
-0.3% -$3.93K 0.43% 67
2022
Q4
$1.68M Sell
32,824
-692
-2% -$33.2K 0.56% 55
2022
Q3
$1.47K Buy
33,516
+271
+0.8% +$13.2K 0.23% 58
2022
Q2
$1.74M Sell
33,245
-285
-0.8% -$14.5K 0.59% 52
2022
Q1
$1.74K Sell
33,530
-246
-0.7% -$12.8K 0.33% 53
2021
Q4
$1.99M Buy
33,776
+3
+0% +$149 0.6% 46
2021
Q3
$1.45M Sell
33,773
-149
-0.4% -$6.6K 0.42% 57
2021
Q2
$1.33M Buy
33,922
+3,297
+11% +$128K 0.45% 61
2021
Q1
$1.11M Sell
30,625
-2,027
-6% -$72K 0.4% 69
2020
Q4
$1.2K Sell
32,652
-1,755
-5% -$64.4K 0.19% 61
2020
Q3
$1.2M Buy
34,407
+527
+2% +$18.5K 0.5% 54
2020
Q2
$1.25M Buy
33,880
+1,856
+6% +$63.1K 0.54% 51
2020
Q1
$1.09M Sell
32,024
-782
-2% -$26.6K 0.57% 45
2019
Q4
$1.22K Buy
32,806
+1,107
+3% +$39.4K 0.13% 58
2019
Q3
$1.08M Sell
31,699
-12,337
-28% -$449K 0.51% 54
2019
Q2
$1.81K Sell
44,036
-713
-2% -$28.3K 0.05% 31
2019
Q1
$1.8M Sell
44,749
-194
-0.4% -$7.77K 0.72% 33
2018
Q4
$1.86K Buy
44,943
+601
+1% +$24.9K 0.16% 37
2018
Q3
$1.89M Buy
44,342
+128
+0.3% +$4.93K 0.83% 37
2018
Q2
$1.52K Sell
44,214
-977
-2% -$33.4K 0.1% 38
2018
Q1
$1.56M Sell
45,191
-2,726
-6% -$93.7K 0.79% 37
2017
Q4
$1.65M Buy
47,917
+406
+0.9% +$13.8K 0.82% 36
2017
Q3
$1.61M Buy
47,511
+15
+0% +$482 0.86% 32
2017
Q2
$1.51M Buy
47,496
+2,807
+6% +$88.5K 0.84% 32
2017
Q1
$1.45K Buy
44,689
+3,153
+8% +$99.4K 0.64% 36
2016
Q4
$1.28M Buy
41,536
+528
+1% +$16.1K 0.78% 37
2016
Q3
$1.32M Buy
41,008
+5,663
+16% +$189K 0.83% 32
2016
Q2
$1.18M Buy
35,345
+2,373
+7% +$75.7K 0.74% 39
2016
Q1
$927K Buy
32,972
+16,955
+106% +$484K 0.67% 41
2015
Q4
$491K Hold
16,017
0.35% 81
2015
Q3
$477K Sell
16,017
-442
-3% -$14.2K 0.31% 75
2015
Q2
$524K Buy
16,459
+395
+2% +$12.9K 0.38% 71
2015
Q1
$530K Sell
16,064
-105
-0.6% -$3.34K 0.38% 76
2014
Q4
$478 Hold
16,169
0.29% 83
2014
Q3
$455K Buy
16,169
+403
+3% +$11.3K 0.34% 82
2014
Q2
$444 Sell
15,766
-5,797
-27% -$165K 0.25% 88
2014
Q1
$657K Buy
21,563
+211
+1% +$6.29K 0.47% 69
2013
Q4
$621 Buy
21,352
+401
+2% +$11.7K 0.03% 72
2013
Q3
$571K Buy
20,951
+316
+2% +$8.6K 0.44% 72
2013
Q2
$548 Buy
+20,635
New +$570K 0.04% 69

Other funds holding PFE

Newman Dignan & Sheerar Inc's PFE Position: Q2 2026 in Review

Newman Dignan & Sheerar Inc increased its Pfizer (PFE) stake by 0.09% in Q2 2026, buying an estimated $392 and bringing the position to 16,944 shares worth $408K. The position accounts for 0.08% of the portfolio, ranked #140.

Newman Dignan & Sheerar Inc first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.99M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Newman Dignan & Sheerar Inc held 16,944 shares of Pfizer worth $408K as of Q2 2026.
  • Newman Dignan & Sheerar Inc bought 15 Pfizer shares in Q2 2026, an estimated $392.
  • Pfizer made up 0.08% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #140 holding.
  • Newman Dignan & Sheerar Inc first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Newman Dignan & Sheerar Inc's Pfizer position peaked at $1.99M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.